Skip to main content
. 2022 Apr 11;14(4):833. doi: 10.3390/pharmaceutics14040833

Figure 4.

Figure 4

Representative cartoon highlighting the assessment and confirmation of ultrasound-mediated BBB disruption using CE-T1 MRI. (Created with Biorender.com (accessed on 12 March 2022)).